Clinical Trials Browser

Phase 1/2 × Advanced Cancer × Ipilimumab × Clear all

NCT03459222 2025-04-02

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Phase 1/2 Completed

Advanced Cancer